HOWL
Werewolf Therapeutics, Inc.
Company overview
- Market capitalization
- $45.20M
- Employees
- 39
- Latest publication
- 2026-09-29
About Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. In addition, it develops WTX-1011, a conditionally activated INDUCER T cell engager molecule that targets STEAP 1 for prostate cancer, as well as WTX-2022 that targets CDH6 for ovarian and kidney cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | -49,000USD | 49,000USD | 1,143,000USD |
| Cost Of Revenue | 398,000USD | 400,000USD | — | 406,000USD | 426,000USD | 442,000USD | 454,000USD | 454,000USD |
| Gross Profit | -398,000USD | -400,000USD | — | -406,000USD | -426,000USD | -967,000USD | -454,000USD | 689,000USD |
| Research Development | 8,181,000USD | 6,933,000USD | 11,634,000USD | 13,143,000USD | 13,120,000USD | 15,727,000USD | 12,528,000USD | 15,271,000USD |
| Selling General Administrative | 5,090,000USD | 2,485,000USD | 4,091,999USD | 4,399,000USD | 4,871,000USD | 4,621,000USD | 4,596,000USD | 4,832,000USD |
| Unclassified Operating Expenses | -4,703,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 8,568,000USD | 9,418,000USD | 15,726,000USD | 17,136,000USD | 17,565,000USD | 20,348,000USD | 17,124,000USD | 19,649,000USD |
| Operating Income | -8,966,000USD | -9,418,000USD | -15,726,000USD | -17,542,000USD | -17,991,000USD | -20,348,000USD | -17,124,000USD | -18,960,000USD |
| Interest Income | 433,000USD | 564,000USD | 697,000USD | 850,000USD | 997,000USD | 1,309,000USD | 1,598,000USD | 1,793,000USD |
| Interest Expense | 1,368,000USD | 1,369,000USD | 644,000USD | 1,301,000USD | 1,263,000USD | 1,267,000USD | 1,244,000USD | 1,142,000USD |
| Net Interest Income | -935,000USD | -805,000USD | -644,000USD | -451,000USD | -266,000USD | 42,000USD | 354,000USD | 651,000USD |
| Income Before Tax | -13,532,000USD | -8,381,000USD | -16,370,000USD | -17,982,000USD | -18,089,000USD | -20,400,000USD | -16,673,000USD | -17,249,000USD |
| Net Income | -13,532,000USD | -8,381,000USD | -16,370,000USD | -17,982,000USD | -18,089,000USD | -20,400,000USD | -16,673,000USD | -17,249,000USD |
| Net Income From Continuing Ops | -13,532,000USD | -8,381,000USD | -16,370,000USD | -17,982,000USD | -18,089,000USD | -20,400,000USD | -16,673,000USD | -17,249,000USD |
| Ebit | -8,966,000USD | -7,012,000USD | -15,726,000USD | -16,681,000USD | -16,826,000USD | -19,133,000USD | -15,429,000USD | -16,107,000USD |
| Ebitda | -8,568,000USD | -6,612,000USD | -15,324,000USD | -16,275,000USD | -16,400,000USD | -18,691,000USD | -14,975,000USD | -15,653,000USD |
| Depreciation And Amortization | 398,000USD | 400,000USD | 402,000USD | 406,000USD | 426,000USD | 442,000USD | 454,000USD | 454,000USD |
| Reconciled Depreciation | 398,000USD | 400,000USD | 402,000USD | 406,000USD | 426,000USD | 442,000USD | 454,000USD | 454,000USD |
| Total Other Income Expense Net | -4,566,000USD | 1,037,000USD | -644,000USD | -440,000USD | -98,000USD | -52,000USD | 451,000USD | 1,711,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 454,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 1,885,000USD | 19,943,000USD | 16,401,000USD | 4,148,000USD | 0USD | 0USD |
| Cost Of Revenue | 1,634,000USD | 1,814,000USD | 1,764,000USD | 2,510,000USD | 735,000USD | 777,000USD | 463,000USD |
| Gross Profit | -1,634,000USD | 71,000USD | 18,179,000USD | 16,401,000USD | -735,000USD | -777,000USD | -463,000USD |
| Research Development | 44,830,000USD | 56,434,000USD | 41,776,000USD | 53,761,000USD | 35,269,000USD | 16,641,000USD | 6,340,000USD |
| Selling General Administrative | 15,847,000USD | 19,045,000USD | 18,670,000USD | 18,696,000USD | 14,818,000USD | 5,763,000USD | 3,596,000USD |
| Unclassified Operating Expenses | -1,634,000USD | -1,814,000USD | -1,764,000USD | — | — | — | — |
| Total Operating Expenses | 59,043,000USD | 73,665,000USD | 58,682,000USD | 72,457,000USD | 50,087,000USD | 21,627,000USD | 9,936,000USD |
| Operating Income | -60,677,000USD | -73,594,000USD | -40,503,000USD | -56,056,000USD | -50,087,000USD | -22,404,000USD | -9,936,000USD |
| Interest Income | 3,108,000USD | 6,673,000USD | 4,491,000USD | 1,908,000USD | 104,000USD | 63,000USD | — |
| Interest Expense | 5,274,000USD | 4,656,000USD | 3,139,000USD | 1,104,000USD | 216,000USD | 101,000USD | 372,000USD |
| Net Interest Income | -2,166,000USD | 2,017,000USD | 4,491,000USD | 1,908,000USD | 104,000USD | 101,000USD | -372,000USD |
| Income Before Tax | -60,822,000USD | -70,515,000USD | -37,368,000USD | -53,810,000USD | -49,983,000USD | -15,040,000USD | -10,248,000USD |
| Net Income | -60,822,000USD | -70,515,000USD | -37,368,000USD | -51,564,000USD | -49,767,000USD | -14,939,000USD | -10,990,000USD |
| Net Income From Continuing Ops | -60,822,000USD | -70,515,000USD | -37,295,000USD | -53,810,000USD | -49,983,000USD | -15,040,000USD | -10,248,000USD |
| Ebit | -60,677,000USD | -65,859,000USD | -34,229,000USD | -56,056,000USD | -50,087,000USD | -15,040,000USD | -9,876,000USD |
| Ebitda | -59,043,000USD | -64,045,000USD | -32,465,000USD | -54,952,000USD | -49,871,000USD | -14,263,000USD | -9,413,000USD |
| Depreciation And Amortization | 1,634,000USD | 1,814,000USD | 1,764,000USD | 1,104,000USD | 216,000USD | 777,000USD | 463,000USD |
| Reconciled Depreciation | 1,634,000USD | 1,814,000USD | 1,721,000USD | 1,104,000USD | 216,000USD | 150,000USD | 25,000USD |
| Total Other Income Expense Net | -145,000USD | 3,079,000USD | 3,135,000USD | 2,246,000USD | 104,000USD | 7,364,000USD | -312,000USD |
| Income Tax Expense | — | — | 1,596,105USD | -2,246,000USD | -216,000USD | -101,000USD | 742,000USD |
| Non Operating Income Net Other | — | — | — | 2,246,000USD | 104,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -53,810,000USD | 101,959,000USD | -28,217,000USD | -18,229,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 24,155,000USD | 58,022,000USD | 69,396,000USD | 79,627,000USD | 92,566,000USD | 107,236,000USD | 126,929,000USD | 140,036,000USD |
| Cash And Equivalents | 21,987,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 22,892,000USD | 48,734,000USD | 58,586,000USD | 68,173,000USD | 80,439,000USD | 94,457,000USD | 113,066,000USD | 125,835,000USD |
| Other Current Assets | 905,000USD | 2,284,000USD | 1,536,000USD | 2,462,000USD | 2,843,000USD | 2,415,000USD | 2,071,000USD | 3,008,000USD |
| Other Non Current Assets | 0USD | — | — | — | — | — | — | — |
| Total Liabilities | 7,863,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 7,863,000USD | 38,519,000USD | 36,148,000USD | 17,603,000USD | 15,171,000USD | 11,669,000USD | 15,180,000USD | 12,464,000USD |
| Other Current Liabilities | 5,924,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 16,292,000USD | 12,202,000USD | 24,805,000USD | 29,614,000USD | 41,464,000USD | 57,307,000USD | 73,390,000USD | 89,379,000USD |
| Total Equity Including Noncontrolling Interest | 16,292,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,263,000USD | 9,288,000USD | 9,904,000USD | 10,510,000USD | 11,110,000USD | 11,709,000USD | 12,323,000USD | 12,943,000USD |
| Accounts Payable | 1,939,000USD | 3,569,000USD | 754,000USD | 1,078,000USD | 2,774,000USD | 986,000USD | 3,035,000USD | 1,240,000USD |
| Short Term Debt | 0USD | 30,435,000USD | 29,987,000USD | 7,504,000USD | 3,854,000USD | 1,412,000USD | 1,557,000USD | 1,320,000USD |
| Common Stock | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD |
| Retained Earnings | -485,272,000USD | -488,942,000USD | -475,410,000USD | -467,029,000USD | -450,659,000USD | -432,677,000USD | -414,588,000USD | -394,188,000USD |
| Total Liab | — | 45,820,000USD | 44,591,000USD | 50,013,000USD | 51,102,000USD | 49,929,000USD | 53,539,000USD | 50,657,000USD |
| Other Current Liab | — | 4,515,000USD | 5,407,000USD | 9,021,000USD | 8,543,000USD | 9,271,000USD | 10,588,000USD | 9,904,000USD |
| Capital Stock | — | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 5,000USD | 4,000USD |
| Cash | — | 46,450,000USD | 57,050,000USD | 65,711,000USD | 77,596,000USD | 92,042,000USD | 110,995,000USD | 122,827,000USD |
| Cash And Short Term Investments | — | 46,450,000USD | 57,050,000USD | 65,711,000USD | 77,596,000USD | 92,042,000USD | 110,995,000USD | 122,827,000USD |
| Net Debt | — | -8,799,000USD | -19,379,000USD | -28,411,000USD | -40,450,000USD | -55,028,000USD | -73,908,000USD | -86,049,000USD |
| Short Long Term Debt | — | 28,831,000USD | 28,236,000USD | 6,000,000USD | 2,400,000USD | — | — | — |
| Short Long Term Debt Total | — | 37,651,000USD | 37,671,000USD | 37,300,000USD | 37,146,000USD | 37,014,000USD | 37,087,000USD | 36,778,000USD |
| Property Plant Equipment Gross | — | 9,288,000USD | 16,522,000USD | 10,510,000USD | 11,110,000USD | 11,709,000USD | 17,307,000USD | 12,943,000USD |
| Common Stock Shares Outstanding | — | 49,388,181shares | 46,810,252shares | 45,804,042shares | 44,981,746shares | 44,827,159shares | 44,478,140shares | 43,704,836shares |
| Non Current Assets Total | — | 9,287,999USD | 10,810,000USD | 11,454,000USD | 12,127,000USD | 12,779,000USD | 13,863,000USD | 14,201,000USD |
| Non Current Liabilities Total | — | 7,301,000USD | 8,443,000USD | 32,410,000USD | 35,931,000USD | 38,260,000USD | 38,359,000USD | 38,193,000USD |
| Net Working Capital | — | 10,215,000USD | 22,438,000USD | 50,570,000USD | 65,268,000USD | 82,788,000USD | 97,886,000USD | 113,371,000USD |
| Unclassified Current Liabilities | — | -28,831,000USD | -28,236,000USD | -6,000,000USD | -2,400,000USD | — | — | — |
| Unclassified Non Current Liabilities | — | 7,301,000USD | 8,443,000USD | 10,754,000USD | 11,226,000USD | 11,675,000USD | 12,264,000USD | 12,576,000USD |
| Unclassified Equity | — | 501,134,000USD | 500,205,000USD | 496,633,000USD | 492,113,000USD | 489,974,000USD | 487,968,000USD | 483,559,000USD |
| Non Currrent Assets Other | — | — | 906,000USD | 944,000USD | 1,017,000USD | 179,000USD | 320,000USD | 1,258,000USD |
| Long Term Debt | — | — | — | 21,656,000USD | 24,705,000USD | 26,585,000USD | 26,095,000USD | 25,617,000USD |
| Other Assets | — | — | — | — | — | — | -2,572,000USD | — |
| Unclassified Non Current Assets | — | — | — | — | — | — | 1,220,000USD | — |
| Short Term Investments | — | — | — | — | — | — | — | 1,216,000USD |
| Net Receivables | — | — | — | — | — | — | — | 464,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -1,680,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 69,396,000USD | 126,929,000USD | 174,833,000USD | 160,245,000USD | 179,250,000USD | 96,398,000USD | 21,679,000USD |
| Other Current Assets | 635,000USD | 2,071,000USD | 2,677,000USD | 3,957,000USD | 3,537,000USD | 344,000USD | 167,000USD |
| Total Liab | 44,591,000USD | 53,539,000USD | 63,459,000USD | 37,908,000USD | 26,463,000USD | 7,179,000USD | 11,910,000USD |
| Total Stockholder Equity | 24,805,000USD | 73,390,000USD | 111,374,000USD | 122,337,000USD | 152,787,000USD | 89,219,000USD | 9,769,000USD |
| Other Current Liab | 33,643,000USD | 10,588,000USD | 8,860,000USD | 14,152,000USD | 8,765,000USD | 3,586,001USD | 816,000USD |
| Common Stock | 5,000USD | 5,000USD | 4,000USD | 3,000USD | 2,000USD | 2,000USD | 2,000USD |
| Capital Stock | 5,000USD | 5,000USD | 4,000USD | 3,000USD | 2,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -475,410,000USD | -414,588,000USD | -344,073,000USD | -306,705,000USD | -252,895,000USD | -51,865,000USD | -24,408,000USD |
| Cash | 57,951,000USD | 110,995,000USD | 134,343,000USD | 129,315,000USD | 157,531,000USD | 92,570,000USD | 17,896,000USD |
| Cash And Short Term Investments | 57,951,000USD | 110,995,000USD | 134,343,000USD | 129,315,000USD | 157,531,000USD | 92,570,000USD | 17,896,000USD |
| Total Current Assets | 58,586,000USD | 113,066,000USD | 138,370,000USD | 140,200,000USD | 161,068,000USD | 92,914,000USD | 18,063,000USD |
| Total Current Liabilities | 36,148,000USD | 15,180,000USD | 19,378,000USD | 23,989,000USD | 11,874,000USD | 5,284,000USD | 2,044,000USD |
| Net Debt | -48,516,000USD | -73,908,000USD | -82,420,000USD | -114,631,000USD | -141,870,000USD | -90,029,000USD | -14,759,000USD |
| Short Term Debt | 1,751,000USD | 1,557,000USD | 8,275,000USD | 2,084,000USD | 1,072,000USD | 677,000USD | 595,000USD |
| Short Long Term Debt | 28,236,000USD | — | 6,667,000USD | — | — | — | — |
| Short Long Term Debt Total | 9,435,000USD | 37,087,000USD | 51,923,000USD | 14,684,000USD | 15,661,000USD | 2,541,000USD | 3,137,000USD |
| Accounts Payable | 754,000USD | 3,035,000USD | 1,336,000USD | 1,221,000USD | 2,037,000USD | 1,020,999USD | 633,000USD |
| Property Plant Equipment Net | 9,904,000USD | 12,323,000USD | 14,846,000USD | 17,451,000USD | 16,325,000USD | 3,122,000USD | 3,408,000USD |
| Property Plant Equipment Gross | 16,522,000USD | 17,307,000USD | 18,016,000USD | 8,988,000USD | 2,913,000USD | 3,122,000USD | 3,408,000USD |
| Common Stock Shares Outstanding | 46,810,252shares | 43,859,664shares | 35,646,572shares | 28,864,000shares | 18,455,000shares | 28,664,359shares | 28,664,359shares |
| Non Current Assets Total | 10,810,000USD | 13,863,000USD | 36,463,000USD | 20,045,000USD | 18,182,000USD | 3,484,000USD | 3,616,000USD |
| Non Current Liabilities Total | 8,443,000USD | 38,359,000USD | 44,081,000USD | 13,919,000USD | 14,589,000USD | 1,895,000USD | 9,866,000USD |
| Non Currrent Assets Other | 5,000USD | 320,000USD | 594,000USD | 1,380,000USD | 1,857,000USD | 362,000USD | 208,000USD |
| Net Working Capital | 22,438,000USD | 97,886,000USD | 118,992,000USD | 116,211,000USD | 149,194,000USD | 87,630,000USD | 16,019,000USD |
| Unclassified Current Liabilities | -28,236,000USD | — | -6,667,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | 8,443,000USD | 12,264,000USD | 11,425,000USD | 1,319,000USD | 14,589,000USD | 1,678,000USD | 2,519,000USD |
| Unclassified Equity | 500,205,000USD | 487,968,000USD | 455,439,000USD | 429,036,000USD | 584,928,000USD | 282,164,000USD | 34,173,000USD |
| Long Term Debt | — | 26,095,000USD | 32,656,000USD | — | — | — | — |
| Unclassified Non Current Assets | — | 1,220,000USD | 21,022,999USD | -9,671,000USD | -1,857,000USD | — | — |
| Other Assets | — | — | 1USD | 10,885,000USD | 1,857,000USD | 362,000USD | 208,000USD |
| Current Deferred Revenue | — | — | 907,000USD | 6,532,000USD | — | — | — |
| Net Receivables | — | — | 1,350,000USD | 6,928,000USD | — | — | — |
| Inventory | — | — | — | 2USD | — | — | — |
| Non Current Liabilities Other | — | — | — | 12,600,000USD | — | 31,000USD | 23,000USD |
| Net Tangible Assets | — | — | — | 122,337,000USD | 152,787,000USD | -51,863,000USD | -24,304,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | -179,250,000USD | -141,084,000USD | 0USD |
| Deferred Long Term Liab | — | — | — | — | — | 155,000USD | — |
| Other Liab | — | — | — | — | — | 31,000USD | 7,324,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -13,532,000USD | -8,381,000USD | -16,370,000USD | -17,982,000USD | -18,089,000USD | -20,400,000USD | -16,672,999USD | -17,249,000USD |
| Depreciation | 398,000USD | 400,000USD | 402,000USD | 406,000USD | 426,000USD | 442,000USD | 454,000USD | 454,000USD |
| Stock Based Compensation | 929,000USD | 1,213,000USD | 1,233,000USD | 1,793,000USD | 2,005,999USD | 1,908,000USD | 2,011,000USD | 2,602,000USD |
| Other Non Cash Items | 1,068,000USD | -1,069,000USD | 752,000USD | 694,000USD | -2,858,999USD | 3,340,000USD | 1,365,999USD | 978,000USD |
| Change In Working Capital | 1,469,000USD | -3,187,000USD | 60,000USD | -75,000USD | -432,000USD | 458,000USD | 380,000USD | -962,000USD |
| Total Cash From Operating Activities | -10,597,000USD | -11,024,000USD | -15,156,000USD | -15,164,000USD | -18,948,000USD | -14,252,000USD | -12,462,000USD | -14,177,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | -123,000USD | -3,000USD | -17,000USD |
| Free Cash Flow | -10,597,000USD | -11,024,000USD | -15,156,000USD | -15,164,000USD | -18,948,000USD | -14,375,000USD | -12,465,000USD | -14,193,999USD |
| Change In Cash | -10,600,000USD | -8,658,000USD | -11,882,000USD | -14,776,000USD | -18,948,000USD | -11,828,000USD | -12,471,000USD | -23,914,000USD |
| Begin Period Cash Flow | 57,050,000USD | 66,609,000USD | 78,491,000USD | 93,267,000USD | 112,215,000USD | 124,043,000USD | 136,514,000USD | 160,428,000USD |
| End Period Cash Flow | 46,450,000USD | 57,951,000USD | 66,608,999USD | 78,491,000USD | 93,267,000USD | 112,215,000USD | 124,043,000USD | 136,514,000USD |
| Net Borrowings | — | 0USD | 0USD | — | — | 0USD | 0USD | — |
| Total Cash From Financing Activities | — | 2,366,000USD | 3,274,000USD | 388,000USD | 0USD | 2,547,000USD | -6,000USD | -9,720,000USD |
| Issuance Of Capital Stock | — | 2,318,000USD | 3,274,000USD | 347,000USD | 0USD | 2,481,000USD | -29,000USD | 877,000USD |
| Other Cashflows From Financing Activities | — | 2,366,000USD | 3,274,000USD | 388,000USD | — | 2,547,000USD | 23,000USD | -9,720,000USD |
| Unclassified Financing Cash Flow | — | -2,318,000USD | -3,274,000USD | — | — | -2,481,000USD | — | — |
| Investments | — | — | 0USD | 0USD | 0USD | -123,000USD | -3,000USD | -17,000USD |
| Unclassified Operating Cash Flow | — | — | -1,233,000USD | — | — | — | — | — |
| Change To Account Receivables | — | — | — | — | — | 464,000USD | 81,000USD | 230,000USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | -123,000USD | -3,000USD | -17,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | -6,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -60,822,000USD | -70,515,000USD | -37,368,000USD | -53,810,000USD | -49,983,000USD | -15,040,000USD | -10,248,000USD |
| Depreciation | 1,634,000USD | 1,814,000USD | 1,764,000USD | 1,104,000USD | 216,000USD | 150,000USD | 25,000USD |
| Stock Based Compensation | 6,245,000USD | 8,826,000USD | 8,008,000USD | 7,400,000USD | 4,095,000USD | 632,000USD | 559,000USD |
| Other Non Cash Items | 856,000USD | 1,161,000USD | 878,000USD | 2,171,000USD | 519,000USD | -6,286,000USD | 950,000USD |
| Change In Working Capital | -8,205,000USD | 2,526,000USD | -5,894,000USD | 2,539,000USD | 2,277,000USD | 1,920,000USD | -711,000USD |
| Total Cash From Operating Activities | -60,292,000USD | -56,188,000USD | -32,612,000USD | -40,596,000USD | -42,876,000USD | -18,624,000USD | -9,542,000USD |
| Capital Expenditures | 0USD | -254,000USD | -769,000USD | -3,611,000USD | -498,000USD | -560,000USD | -266,000USD |
| Free Cash Flow | -60,292,000USD | -56,442,000USD | -33,381,000USD | -44,207,000USD | -43,374,000USD | -19,183,999USD | -9,808,000USD |
| Net Borrowings | 0USD | -10,000,000USD | 40,000,000USD | -88,000USD | — | — | — |
| Total Cash From Financing Activities | 6,028,000USD | 13,080,000USD | 58,429,000USD | 15,906,000USD | 109,427,000USD | 93,857,000USD | 21,909,000USD |
| Issuance Of Capital Stock | 5,939,000USD | 23,576,000USD | 10,877,000USD | 16,191,000USD | 111,600,000USD | 94,170,000USD | 22,102,000USD |
| Change In Cash | -54,264,000USD | -43,362,000USD | 25,048,000USD | -28,301,000USD | 66,053,000USD | 74,673,000USD | 12,101,000USD |
| Begin Period Cash Flow | 112,215,000USD | 155,577,000USD | 130,529,000USD | 158,830,000USD | 92,777,000USD | 18,104,000USD | 6,003,000USD |
| End Period Cash Flow | 57,951,000USD | 112,215,000USD | 155,577,000USD | 130,529,000USD | 158,830,000USD | 92,777,000USD | 18,104,000USD |
| Other Cashflows From Financing Activities | 6,028,000USD | -496,000USD | 100,000USD | 166,000USD | -2,173,000USD | 93,857,000USD | 21,907,000USD |
| Unclassified Financing Cash Flow | -5,939,000USD | — | 7,452,000USD | — | 2,173,000USD | -94,170,000USD | -22,100,000USD |
| Change To Account Receivables | — | 1,350,000USD | 5,578,000USD | -6,928,000USD | — | — | — |
| Investments | — | -254,000USD | -1,089,000USD | -3,611,000USD | -498,000USD | -560,000USD | -266,000USD |
| Total Cashflows From Investing Activities | — | -254,000USD | -769,000USD | -3,611,000USD | -498,000USD | -560,000USD | -266,000USD |
| Unclassified Investing Cash Flow | — | — | 1,089,000USD | 3,611,000USD | — | — | — |
| Change To Inventory | — | — | — | 6,928,000USD | — | — | — |
| Change To Liabilities | — | — | — | 3,046,000USD | 1,007,000USD | 388,000USD | 116,000USD |
| Sale Purchase Of Stock | — | — | — | 15,994,000USD | 109,427,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -28,301,000USD | 66,053,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.